| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |